About Impute.me
Impute.me was established in 2015 in France as a provider of non-profit tools that leverage data services. Operations center on delivering imputation and analysis functionalities for genetic and health data, supporting research and personalization efforts. The company functions within the data services sector, emphasizing open-access resources for scientific communities across Europe and beyond. Services are maintained through an online platform accessible via its domain.
- Headquarter France
-
Sectors
Government & Social Sector
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 24Genetics Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Nucleus Genomics
(Jul 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Impute.me
Detailed funding history for Impute.me
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Impute.me
Impute.me has secured backing from 1 investor. Prominent investors backing the company include Nucleus Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of genetic testing kits for rare variant analysis
|
Locked | Locked | Locked |
Investor details for Impute.me
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Impute.me
Investment portfolio details for Impute.me
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Impute.me
Detailed financials for Impute.me
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Impute.Me Comparisons
Peer comparison for Impute.me
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Impute.me
Detailed competitors of Impute.me
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Impute.Me
Complete news archive for Impute.me
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impute.me
Impute.me was founded in 2015.
Impute.me is headquartered in France.
Impute.me was established in 2015 in France as a provider of non-profit tools that leverage data services. Operations center on delivering imputation and analysis functionalities for genetic and health data, supporting research and personalization efforts. The company functions within the data services sector, emphasizing open-access resources for scientific communities across Europe and beyond. Services are maintained through an online platform accessible via its domain.
Impute.me has 1 investor. Key investors include Nucleus Genomics.